NASDAQ:CTRE - Caretrust REIT Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $22.42 +0.26 (+1.17 %) (As of 02/19/2019 04:01 AM ET)Previous Close$22.16Today's Range$22.01 - $22.4552-Week Range$12.73 - $22.87Volume874,824 shsAverage Volume990,400 shsMarket Capitalization$1.88 billionP/E Ratio17.52Dividend Yield3.70%Beta0.92 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition and leasing of seniors housing and healthcare-related properties. With 192 net-leased healthcare properties and three operated seniors housing properties in 27 states, CareTrust REIT is pursuing opportunities across the nation to acquire properties that will be leased to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses. Receive CTRE News and Ratings via Email Sign-up to receive the latest news and ratings for CTRE and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Real estate investment trusts Sub-IndustryN/A SectorFinance Current SymbolNASDAQ:CTRE Previous SymbolNASDAQ:CTREV CUSIPN/A Webwww.caretrustreit.com Phone949-542-3130Debt Debt-to-Equity Ratio0.67 Current Ratio1.52 Quick Ratio1.52Price-To-Earnings Trailing P/E Ratio17.52 Forward P/E Ratio16.36 P/E GrowthN/A Sales & Book Value Annual Sales$156.94 million Price / Sales11.98 Cash Flow$0.9326 per share Price / Cash Flow24.04 Book Value$7.83 per share Price / Book2.86Profitability EPS (Most Recent Fiscal Year)$1.28 Net Income$25.87 million Net Margins36.91% Return on Equity8.90% Return on Assets4.73%Miscellaneous Employees50 Outstanding Shares83,884,000Market Cap$1.88 billion OptionableOptionable Caretrust REIT (NASDAQ:CTRE) Frequently Asked Questions What is Caretrust REIT's stock symbol? Caretrust REIT trades on the NASDAQ under the ticker symbol "CTRE." How often does Caretrust REIT pay dividends? What is the dividend yield for Caretrust REIT? Caretrust REIT declared a quarterly dividend on Tuesday, December 18th. Stockholders of record on Monday, December 31st will be paid a dividend of $0.205 per share on Tuesday, January 15th. This represents a $0.82 annualized dividend and a dividend yield of 3.66%. The ex-dividend date is Friday, December 28th. View Caretrust REIT's Dividend History. How were Caretrust REIT's earnings last quarter? Caretrust REIT Inc (NASDAQ:CTRE) released its earnings results on Wednesday, February, 13th. The real estate investment trust reported $0.18 EPS for the quarter, missing the Zacks' consensus estimate of $0.32 by $0.14. The real estate investment trust had revenue of $40.36 million for the quarter, compared to the consensus estimate of $39.99 million. Caretrust REIT had a return on equity of 8.90% and a net margin of 36.91%. The company's revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the company earned $0.31 EPS. View Caretrust REIT's Earnings History. When is Caretrust REIT's next earnings date? Caretrust REIT is scheduled to release their next quarterly earnings announcement on Tuesday, May 14th 2019. View Earnings Estimates for Caretrust REIT. What guidance has Caretrust REIT issued on next quarter's earnings? Caretrust REIT issued an update on its FY19 earnings guidance on Wednesday, February, 13th. The company provided EPS guidance of $1.30-1.32 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.36. Caretrust REIT also updated its FY 2019 guidance to $1.30-1.32 EPS. What price target have analysts set for CTRE? 7 Wall Street analysts have issued 1-year target prices for Caretrust REIT's shares. Their predictions range from $18.00 to $22.00. On average, they anticipate Caretrust REIT's share price to reach $20.50 in the next year. This suggests that the stock has a possible downside of 8.6%. View Analyst Price Targets for Caretrust REIT. What is the consensus analysts' recommendation for Caretrust REIT? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Caretrust REIT in the last year. There are currently 1 hold rating, 5 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Caretrust REIT. What are Wall Street analysts saying about Caretrust REIT stock? Here are some recent quotes from research analysts about Caretrust REIT stock: 1. According to Zacks Investment Research, "CareTrust REIT, Inc. is a real estate investment trust. It is primarily engaged in the ownership, acquisition and leasing of healthcare-related properties. The Company leases healthcare facilities to healthcare operators in triple-net lease arrangements. CareTrust REIT, Inc. is based in United States. " (2/4/2019) 2. Cantor Fitzgerald analysts commented, "We rate CTRE 12-month price target of $20. We believe that the market underappreciates the skilled nursing opportunity and that CTRE is well positioned to capitalize on the consolidation of the skilled nursing market. In our view, the skilled nursing industry is well-positioned to provide post-acute care like short-stay rehab and capitalize on the increasingly value-based reimbursement market. 12-month price target of $20 is based on a blended approach of discounted cash flow analysis and comparable-company analysis." (11/5/2018) Has Caretrust REIT been receiving favorable news coverage? Media coverage about CTRE stock has been trending positive on Tuesday, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Caretrust REIT earned a coverage optimism score of 2.3 on InfoTrie's scale. They also assigned news coverage about the real estate investment trust a news buzz of 6.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the stock's share price in the near future. Who are some of Caretrust REIT's key competitors? Some companies that are related to Caretrust REIT include Kimco Realty (KIM), Kilroy Realty (KRC), Omega Healthcare Investors (OHI), Liberty Property Trust (LPT), Store Capital (STOR), American Homes 4 Rent (AMH), Medical Properties Trust (MPW), Douglas Emmett (DEI), American Campus Communities (ACC), Macerich (MAC), CyrusOne (CONE), Starwood Property Trust (STWD), Healthcare Trust Of America (HTA), New Residential Investment (NRZ) and CubeSmart (CUBE). Who are Caretrust REIT's key executives? Caretrust REIT's management team includes the folowing people: Mr. Gregory K. Stapley J.D., Chairman, Pres & CEO (Age 59)Mr. William M. Wagner, CFO, Treasurer & Sec. (Age 53)Mr. David M. Sedgwick, Chief Operating Officer (Age 43)Mr. Mark D. Lamb, Chief Investment OfficerMr. Eric Gillis, Director of Asset Management Who are Caretrust REIT's major shareholders? Caretrust REIT's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (19.12%), Millennium Management LLC (2.39%), Northern Trust Corp (2.17%), Bank of New York Mellon Corp (1.83%), Weiss Multi Strategy Advisers LLC (1.70%) and Dimensional Fund Advisors LP (1.47%). View Institutional Ownership Trends for Caretrust REIT. Which institutional investors are selling Caretrust REIT stock? CTRE stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Millennium Management LLC, Bank of America Corp DE, Hsbc Holdings PLC, Keeley Teton Advisors LLC, Westpac Banking Corp, Amundi Pioneer Asset Management Inc. and MetLife Investment Advisors LLC. View Insider Buying and Selling for Caretrust REIT. Which institutional investors are buying Caretrust REIT stock? CTRE stock was bought by a variety of institutional investors in the last quarter, including Weiss Multi Strategy Advisers LLC, Oregon Public Employees Retirement Fund, Northern Trust Corp, D. E. Shaw & Co. Inc., Two Sigma Investments LP, UBS Oconnor LLC, Two Sigma Advisers LP and Monarch Partners Asset Management LLC. View Insider Buying and Selling for Caretrust REIT. How do I buy shares of Caretrust REIT? Shares of CTRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Caretrust REIT's stock price today? One share of CTRE stock can currently be purchased for approximately $22.42. How big of a company is Caretrust REIT? Caretrust REIT has a market capitalization of $1.88 billion and generates $156.94 million in revenue each year. The real estate investment trust earns $25.87 million in net income (profit) each year or $1.28 on an earnings per share basis. Caretrust REIT employs 50 workers across the globe. What is Caretrust REIT's official website? The official website for Caretrust REIT is http://www.caretrustreit.com. How can I contact Caretrust REIT? Caretrust REIT's mailing address is 905 CALLE AMANECER SUITE 300, SAN CLEMENTE CA, 92673. The real estate investment trust can be reached via phone at 949-542-3130 or via email at [email protected] MarketBeat Community Rating for Caretrust REIT (NASDAQ CTRE)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 283 (Vote Outperform)Underperform Votes: 272 (Vote Underperform)Total Votes: 555MarketBeat's community ratings are surveys of what our community members think about Caretrust REIT and other stocks. Vote "Outperform" if you believe CTRE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CTRE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/19/2019 by MarketBeat.com StaffFeatured Article: Why is insider trading harmful?